Concepts (126)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Vena Cava, Superior | 1 | 2018 | 30 | 0.73 | Why? |
| Vascular Malformations | 1 | 2018 | 52 | 0.70 | Why? |
| Diabetic Cardiomyopathies | 1 | 2018 | 79 | 0.66 | Why? |
| Pulmonary Veins | 1 | 2018 | 146 | 0.64 | Why? |
| Hypertrophy, Left Ventricular | 1 | 2018 | 219 | 0.58 | Why? |
| Multidetector Computed Tomography | 1 | 2018 | 307 | 0.55 | Why? |
| Vascular Surgical Procedures | 1 | 2018 | 882 | 0.38 | Why? |
| Computed Tomography Angiography | 1 | 2018 | 2153 | 0.34 | Why? |
| Ventricular Remodeling | 3 | 2018 | 349 | 0.31 | Why? |
| Magnetic Resonance Imaging, Cine | 2 | 2018 | 669 | 0.25 | Why? |
| Tomography, X-Ray Computed | 8 | 2021 | 25144 | 0.24 | Why? |
| Magnetic Resonance Imaging | 1 | 2018 | 6551 | 0.21 | Why? |
| Ventricular Function, Left | 3 | 2018 | 1555 | 0.21 | Why? |
| Aminoimidazole Carboxamide | 1 | 2018 | 6 | 0.20 | Why? |
| Enzyme Activators | 1 | 2018 | 24 | 0.19 | Why? |
| Glucose Metabolism Disorders | 1 | 2018 | 22 | 0.19 | Why? |
| Edema, Cardiac | 1 | 2018 | 33 | 0.19 | Why? |
| Glucose Intolerance | 1 | 2020 | 115 | 0.19 | Why? |
| Bone Remodeling | 1 | 2018 | 59 | 0.18 | Why? |
| Ribonucleotides | 1 | 2018 | 96 | 0.18 | Why? |
| AMP-Activated Protein Kinases | 1 | 2018 | 93 | 0.18 | Why? |
| Osteoblasts | 1 | 2018 | 87 | 0.18 | Why? |
| Osteoporosis, Postmenopausal | 1 | 2018 | 75 | 0.18 | Why? |
| Myocardium | 3 | 2018 | 2323 | 0.18 | Why? |
| Heart Transplantation | 2 | 2018 | 1293 | 0.17 | Why? |
| Cardiopulmonary Bypass | 1 | 2018 | 158 | 0.17 | Why? |
| Myocardial Contraction | 1 | 2018 | 123 | 0.16 | Why? |
| Stilbenes | 1 | 2018 | 113 | 0.16 | Why? |
| Systole | 1 | 2018 | 252 | 0.16 | Why? |
| Diabetes Mellitus, Type 2 | 1 | 2018 | 6166 | 0.16 | Why? |
| Bone Density Conservation Agents | 1 | 2018 | 209 | 0.15 | Why? |
| Observer Variation | 1 | 2018 | 622 | 0.14 | Why? |
| Blood Glucose | 2 | 2020 | 3642 | 0.14 | Why? |
| Cardiomyopathy, Dilated | 1 | 2018 | 251 | 0.14 | Why? |
| Medical Staff | 1 | 2021 | 723 | 0.14 | Why? |
| Glucosides | 1 | 2018 | 359 | 0.13 | Why? |
| Thorax | 2 | 2021 | 1873 | 0.13 | Why? |
| Return to Work | 1 | 2020 | 579 | 0.13 | Why? |
| Anti-Retroviral Agents | 1 | 2020 | 1099 | 0.11 | Why? |
| Fibrosis | 3 | 2021 | 800 | 0.11 | Why? |
| Glycated Hemoglobin A | 1 | 2018 | 1316 | 0.10 | Why? |
| Waiting Lists | 1 | 2018 | 1388 | 0.10 | Why? |
| Hyperglycemia | 1 | 2020 | 1363 | 0.10 | Why? |
| Pneumonia, Viral | 10 | 2021 | 243684 | 0.09 | Why? |
| Odds Ratio | 1 | 2020 | 5861 | 0.09 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.09 | Why? |
| Cardiomyopathies | 1 | 2018 | 997 | 0.09 | Why? |
| Asymptomatic Diseases | 2 | 2018 | 3444 | 0.09 | Why? |
| Predictive Value of Tests | 3 | 2018 | 9537 | 0.09 | Why? |
| Diabetes Complications | 1 | 2020 | 2358 | 0.09 | Why? |
| Coronavirus Infections | 8 | 2020 | 253789 | 0.08 | Why? |
| Logistic Models | 1 | 2020 | 9089 | 0.07 | Why? |
| Artificial Intelligence | 1 | 2020 | 3543 | 0.07 | Why? |
| Male | 16 | 2021 | 367725 | 0.07 | Why? |
| Pneumonia | 2 | 2020 | 5652 | 0.06 | Why? |
| Middle Aged | 12 | 2021 | 270681 | 0.06 | Why? |
| Prognosis | 3 | 2021 | 32490 | 0.06 | Why? |
| Female | 15 | 2021 | 380317 | 0.06 | Why? |
| Case-Control Studies | 2 | 2018 | 17671 | 0.06 | Why? |
| Adult | 10 | 2021 | 244371 | 0.06 | Why? |
| Heart Diseases | 1 | 2018 | 3503 | 0.06 | Why? |
| Betacoronavirus | 8 | 2020 | 204454 | 0.05 | Why? |
| Asymptomatic Infections | 1 | 2020 | 7218 | 0.05 | Why? |
| Reproducibility of Results | 1 | 2018 | 11304 | 0.05 | Why? |
| Coinfection | 1 | 2020 | 6820 | 0.05 | Why? |
| Glucose Transporter Type 4 | 1 | 2018 | 13 | 0.05 | Why? |
| TCF Transcription Factors | 1 | 2018 | 1 | 0.05 | Why? |
| GTPase-Activating Proteins | 1 | 2018 | 36 | 0.05 | Why? |
| Forkhead Box Protein O3 | 1 | 2018 | 30 | 0.05 | Why? |
| Gadolinium DTPA | 1 | 2018 | 45 | 0.05 | Why? |
| Ovariectomy | 1 | 2018 | 53 | 0.05 | Why? |
| 3T3 Cells | 1 | 2018 | 152 | 0.05 | Why? |
| Retrospective Studies | 5 | 2021 | 105322 | 0.05 | Why? |
| Aged | 6 | 2020 | 215776 | 0.04 | Why? |
| ROC Curve | 2 | 2020 | 6024 | 0.04 | Why? |
| Wnt Signaling Pathway | 1 | 2018 | 87 | 0.04 | Why? |
| Humans | 17 | 2021 | 930598 | 0.04 | Why? |
| Diabetes Mellitus | 1 | 2020 | 8207 | 0.04 | Why? |
| Enzyme Activation | 1 | 2018 | 425 | 0.04 | Why? |
| Lung | 3 | 2021 | 31049 | 0.04 | Why? |
| Biomechanical Phenomena | 1 | 2018 | 291 | 0.04 | Why? |
| Risk Factors | 3 | 2021 | 71621 | 0.04 | Why? |
| Creatine Kinase, MB Form | 1 | 2018 | 259 | 0.04 | Why? |
| China | 5 | 2021 | 50654 | 0.04 | Why? |
| Adenosine Triphosphate | 1 | 2018 | 294 | 0.04 | Why? |
| Comorbidity | 1 | 2020 | 34796 | 0.04 | Why? |
| Rats, Sprague-Dawley | 1 | 2018 | 987 | 0.04 | Why? |
| Phosphorylation | 1 | 2018 | 1060 | 0.04 | Why? |
| HIV Infections | 1 | 2020 | 11620 | 0.03 | Why? |
| Biomarkers | 1 | 2018 | 23361 | 0.03 | Why? |
| Patient Discharge | 2 | 2020 | 5696 | 0.03 | Why? |
| Fever | 2 | 2021 | 7795 | 0.03 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.03 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.03 | Why? |
| Chemokines | 1 | 2018 | 1095 | 0.03 | Why? |
| Contrast Media | 1 | 2018 | 1011 | 0.03 | Why? |
| Pandemics | 9 | 2020 | 389249 | 0.03 | Why? |
| Myocardial Ischemia | 1 | 2018 | 781 | 0.03 | Why? |
| Early Diagnosis | 1 | 2020 | 2443 | 0.03 | Why? |
| Disease Models, Animal | 2 | 2018 | 10998 | 0.03 | Why? |
| Troponin I | 1 | 2018 | 1298 | 0.03 | Why? |
| Biopsy | 1 | 2018 | 2811 | 0.02 | Why? |
| Child | 1 | 2018 | 70012 | 0.02 | Why? |
| Apoptosis | 1 | 2018 | 2335 | 0.02 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Oxidative Stress | 1 | 2018 | 2050 | 0.02 | Why? |
| Diagnosis, Differential | 1 | 2020 | 7220 | 0.02 | Why? |
| Survival Rate | 1 | 2020 | 9206 | 0.02 | Why? |
| Longitudinal Studies | 1 | 2021 | 9893 | 0.02 | Why? |
| Hospitalization | 3 | 2021 | 54280 | 0.02 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.02 | Why? |
| Length of Stay | 1 | 2020 | 11042 | 0.01 | Why? |
| Follow-Up Studies | 1 | 2021 | 17020 | 0.01 | Why? |
| Signal Transduction | 1 | 2018 | 7207 | 0.01 | Why? |
| Disease Progression | 1 | 2020 | 13580 | 0.01 | Why? |
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2021 | 13720 | 0.01 | Why? |
| Animals | 2 | 2018 | 78931 | 0.01 | Why? |
| Mice | 1 | 2018 | 21357 | 0.01 | Why? |
| Young Adult | 2 | 2020 | 93724 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Cohort Studies | 1 | 2021 | 36005 | 0.01 | Why? |
| Prospective Studies | 1 | 2021 | 43301 | 0.01 | Why? |
| Intensive Care Units | 1 | 2020 | 29594 | 0.01 | Why? |
| Treatment Outcome | 1 | 2018 | 51732 | 0.01 | Why? |
| Aged, 80 and over | 1 | 2020 | 88759 | 0.01 | Why? |
Cao's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(126)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(76)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_